Discover 3,012 paid clinical trials in Riverside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,012
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
for
Hematologic Malignancies
Location: Duarte CA, Goodyear AZ, Scottsdale AZ, Dallas TX,
Sponsor: Sellas Life Sciences Group
Sex: All
Age: 12+
Code: NCT04588922
Phase 1, Phase 2, Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Los Angeles CA, Scottsdale AZ, Salt Lake City UT,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659782
Phase 2, Recruiting
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
for
Relapsed/Refractory Hematological Malignancies,
Location: Los Angeles CA, Grand Rapids MI, Jacksonville FL,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT07424833
Phase 1, Recruiting
Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
for
Acute Graft Versus Host Disease,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05443425
Phase 1, Recruiting
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
for
Prostate Cancer, Prostate Adenocarcinoma,
Location: Durate CA
Sponsor: City of Hope Medical Center
Sex: Male
Age: 18+
Code: NCT05751434
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Los Angeles CA, Palo Alto CA, Aurora CO, Seattle WA,
Sponsor: University of Iowa
Sex: All
Age: 0+
Code: NCT01193088
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
for
Charcot Marie Tooth Disease
Location: Los Angeles CA, Palo Alto CA, Aurora CO, Seattle WA,
Sponsor: Michael Shy
Sex: All
Age: 0+
Code: NCT01193075
Recruiting
Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study
for
Hematopoietic and Lymphoid System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05772130
Recruiting
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
for
HER2-positive Breast Cancer, Breast Cancer
Location: Los Alamitos CA, Long Beach CA, Albuquerque NM,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07102381
Phase 2, Recruiting
Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes
for
Diabetes Mellitus, Type 1
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18 - 68
Code: NCT03746769
Phase 1, Phase 2, Recruiting
Topical Imiquimod Treatment of Oral Dysplasia
for
Oral Dysplasia, Leukoplakia Oral, Leukoplakia
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT07210775
Phase 1, Phase 2, Recruiting
Early Detection of Advanced Adenomas and Colorectal Cancer
Location: Rancho Mirage CA, Colorado Springs CO, Austin TX,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07091630
Phase 3, Recruiting
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
for
Extensive Stage Small Cell Lung Cancer
Location: Los Angeles CA, Seattle WA, Sioux Falls SD, St Louis MO,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037758
Phase 1, Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn Disease
Location: Newport Beach CA, Anaheim CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07196722
Phase 2, Phase 3, Recruiting
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
for
Hemorrhage
Location: Torrance CA, Lakewood CO, St Louis MO, Chicago IL,
Sponsor: Corza Medical GmbH
Sex: All
Age: 0+
Code: NCT06664775
Phase 3, Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
for
Colitis, Ulcerative
Location: Newport Beach CA, Anaheim CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 12+
Code: NCT07196748
Phase 3, Recruiting
Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
for
Hematologic Malignancies
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07186192
Phase 3, Recruiting
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma